Modifying Effects of 1'-Acetoxychavicol Acetate (ACA) and the Novel Synthetic Retinoids Re-80,Am-580 and Am-55P in a Two-Stage Carcinogenesis Model in Female Rats
Free accessResearch articleFirst published online February, 2004
Modifying Effects of 1'-Acetoxychavicol Acetate (ACA) and the Novel Synthetic Retinoids Re-80,Am-580 and Am-55P in a Two-Stage Carcinogenesis Model in Female Rats
Effects of dietary administration of 1'-acetoxychavicol acetate (ACA) and the novel synthetic retinoids 4-[1-hydroxy-3-oxo-3-(5,6,7,8-tetrahydro-3-hydroxy-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid (Re-80); 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido]benzoic acid (Am-580); and 6-[(3,5-di-tert-butylphenyl) carbamoyl]nicotinic acid (Am-55P) were examined using a two-stage rat carcinogenesis model. A total of 190 female SD rats was treated sequentially with 1,2-dimethylhydrazine (DMH, s.c.); 7,12-dimethylbenz(a)anthracene (DMBA, i.g.); and 2,2'-dihydroxy-di-n-propylnitrosamine (DHPN, in the drinking water) during the first three weeks (DDD-initiation), and an additional 60 rats received the vehicle alone (non-initiation). One week after the completion of the initiation period, they were divided into nine groups and administrated Re-80 (at dose levels of 1.0 or 0.4 ppm), Am-580 (20 or 4 ppm), Am-55P (20 ppm), ACA (100 ppm), all-trans-retinoic acid (10 or 2 ppm) or no supplement in the diet for 33 weeks, until survivors were euthanatized at week 37 weeks. After DDD-initiation, all-trans-retinoic acid at the high dose delayed the development of mammary tumors. The multiplicity of colon tumors in the group fed Am-55P and the incidences of nephroblastomas with ACA or Am-580 were decreased as compared with the control values, but the other chemicals had no modifying effects on tumor development in any organs. Thus, among ACA and the novel synthetic retinoids tested, only Am-55P showed a weak inhibitory effect on a neoplasm of general interest under the present experimental conditions.
Allenby, G., Bocquel M.T., Saunders, M., Kazmer, S., Speck, J., Rosenberger, M., Lovey, A., Kastner, P., Grippo, J.F., Chambon, P., and Levin, A.A. (1993). Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA90, 30—4.
2.
Arafa, H.M., Elmazar, M.M., Hamada, F.M., Reichert, U., Shroot, B., and Nau, H. (2000). Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure. Arch Toxicol73, 547—56.
3.
Bollag, W. and Holdener, E.E. (1992). Retinoids in cancer prevention and therapy. Ann Oncol3, 513—26.
4.
Brooks, S.C. III, Kazmer, S., Levin, A.A., and Yen, A. (1996). Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. Blood87, 227—37.
5.
Cerutti, P.A. (1994). Oxy-radicals and cancer. Lancet344, 862—63.
6.
Chemoprevention Working Group (1999). Prevention of cancer in the next millennium: report of the Chemoprevention Working Group to the American Association for Cancer Research. Cancer Res59, 4743—58.
7.
Cho, Y., Tighe, A.P., and Talmage, D.A. (1997). Retinoic acid induced growth arrest of human breast carcinoma cells requires protein kinase C-alpha expression and activity. J Cell Physiol172, 306—13.
8.
Elmazar, M.M., Ruhl, R., and Nau, H. (2001). Synergistic teratogenic effects induced by retinoids in mice by coadministration of a RARalphaor RARgamma-selective agonist with a RXR-selective agonist. Toxicol Appl Pharmacol170, 2—9.
9.
Elmazer, M.M., Ruhl, R., Reichert, U., Shroot, B., and Nau, H. (1997). RAR alpha-mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: dissection of retinoid receptor-induced pathways. Toxicol Appl Pharmacol146, 21—8.
10.
Fukushima, S., Hagiwara, A., Hirose, M., Yamaguchi, S., Danai, T., and Ito, N. (1991). Modifying effects of various chemicals on preneoplastic and neoplastic lesion development in a wide-spectrum organ carcinogenesis model using F344 rats. Jpn J Cancer Res82, 642—9.
11.
Gianni, M., LiCalzi, M., Terao, M., Guiso, G., Caccia, S., Barbui, T., Rambaldi, A., and Garattini, E. (1996). Am 580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells. Blood87, 1520—31.
12.
Gianni, M., Zanotta, S., Terao, M., Garattini, S., and Garanttini, E. (1993). Effects of synthetic retinoids and retinoic acid isomers on the expression of alkaline phosphatase in F9 teratocarcinoma cells . Biochem Biophys Res Commun196, 252—9.
13.
Hirose, M., Masuda, A., Fukushima, S., and Ito, N. (1988). Effects of subsequent antioxidant treatment on 7,12-dimethylbenz[a]anthracene-initiated carcinogenesis of the mammary gland, ear duct and forestomach in Sprague— Dawley rats. Carcinogenesis9, 101—4.
14.
Hirose, M., Ozaki, K., Takaba, K., Fukushima, S., Shirai, T., and Ito, N. (1991). Modifying effects of the naturally occurring antioxidants γoryzanol, phytic acid, tannic acid and n-tritriacontane-16,18-dione in a rat wide-spectrum organ carcinogenesis model. Carcinogenesis12, 1917— 21.
15.
Hirose, M., Yada, H., Hakoi, K., Takahashi, S., and Ito, N. (1993). Modification of carcinogenesis by α-tocopherol, t-butylhydroquinone, propyl gallate and butylated hydroxytoluene in a rat multi-organ carcinogenesis model. Carcinogenesis14, 2359—64.
16.
Jetten, A.M., Anderson, K., Deas, M.A., Kagechika, H., Lotan, R., Rearick, J.I., and Shudo, K. (1987). New benzoic acid derivatives with retinoid activity: lack of direct correlation between biological activity and binding to cellular retinoic acid binding protein. Cancer Res47, 3523—7.
17.
Kagechika, H. (1994). Novel synthetic retinoid agonists and antagonists . Yakugaku-Zasshi114, 847—62 (in Japanease).
18.
Kagechika, H., Himi, T., Kawachi, E., and Shudo, K. (1989b). Retinobenzoic acids. 4. Conformation of aromatic amides with retinoidal activity. Importance of trans-amide structure for the activity. J Med Chem32, 2292— 96.
19.
Kagechika, H., Kawachi, E., Hashimoto, Y., and Shudo, K. (1989a). Retinobenzoic acids. 2. Structure-activity relationships of chalcone-4-carboxylic acids and flavone-4'-carboxylic acids. J Med Chem32, 834—40.
20.
Kagechika, H., Kawachi, E., Hashimoto, Y., Himi, T., and Shudo, K. (1988). Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J. Med. Chem . 31, 2182—92.
21.
Kawabata, K., Tanaka, T., Yamamoto, T., Ushida, J., Murakami, A., Koshimizu, K., Ohigashi, H., Stoner, G.W., and Mori, H. (2000). Suppression of N-nitrosomethylebenzyramine-induced rat esophageal tumorigenesis by dietary feeding of 1'-acetoxychavicol acetate . Jpn J Cancer Res91, 148— 55.
22.
Kimura, J., Takahashi, S., Ogiso, T., Yoshida, Y., Akagi, K., Hasegawa, R., Kurata, M., Hirose, M., and Shirai, T. (1996). Lack of chemoprevention effects of the monoterpene d-limonene in a rat multi-organ carcinogenesis model. Jpn J Cancer Res87, 589—94.
23.
Kobayashi, Y., Nakae, D., Akai, H., Kishida, H., Okajima, E., Kitayama, W., Denda, A., Tsujiuchi, T., Murakami, A., Koshimizu, K., Ohigashi, H., and Konishi, Y. (1998). Prevention by 1'-acetoxychavicol acetate of the induction but not growth of putative preneoplastic, glutathione S-transferase placental form-positive, focal lesions in the livers of rats fed a cholinedeficient, L-amino acid-defined diet. Carcinogenesis19, 1809—14.
24.
Kondo, A., Ohigashi, H., Murakami, A., Jiwajinda, S., and Koshimizu, K. (1993). 1'-acetoxychavicol acetate as a potent inhibitor of tumor promoter-induced Epstein-Barr virus activation from languas galanga, a traditional Thai condiment. Biosci Biotech Biochem57, 1344—5.
25.
Kulesz-Martin, M.F., Lisafeld, B., Paterson, J., Driscoll, D., Shudo, K., Roop, D.R., and Kisiel, N.D. (1995). Differentiation and tumor response to retinobenzoic acid Re-80 in a malignant conversion model. Cancer Detect Prevent19, 355—66.
26.
Laura, A.H., Caroline, C.S., Fausto, A., Sharon, A.R., Gary, J.K., and Luigi, M.D. (2000). Retinoids in chemoprevention and differentiation therapy. Carcinogenesis21, 1271—9.
27.
Lee, P.P., Darcy, K.M., Shudo, K., and Ip, M.M. (1995a). Interaction of retinoids with steroid and peptide hormones in modulating morphological and functional differentiation of normal rat mammary epithelial cells. Endocrinology136, 1718—30.
28.
Lee, P.P., Lee, M.T., Darcy, K.M., Shudo, K., and Ip, M.M. (1995b). Modulation of normal mammary epithelial cell proliferation, morphogenesis, and functional differentiation by retinoids: a comparison of the retinobenzoic acid derivative Re80 with retinoic acid . Endocrinology136, 1707—17.
29.
Lippman, S.M., Heyman, R.A., Kurie, J.M., Benner, S.E., and Hong, W.K. (1995). Retinoids and chemoprevention: Clinical and basic studies. J Cell Biochem Suppl22, 1—10.
30.
Miyauchi, M., Nishikawa, A., Furukawa, F., Nakamura, H., Son, H.Y., Murakami, A., Koshimizu, K., Ohigashi, H., and Hirose, M. (2000). Inhibitory effects of 1'-acetoxychavicol acetate on n-nitrosobis(2-oxopropyl)-amine-induced initiation of cholangiocarcinogenesis in Syrian hamsters. Jpn J Cancer Res91, 477—81.
31.
Moon, R.C. (1989). Comparative aspects of carotenoids and retinoid as chemopreventive agents for cancer. J Nutr119, 127—34.
32.
Murakami, A., Jiwajinda, S., Koshimizu, K., and Ohigashi, H. (1995). Screening for in vitro anti-tumor promoting activities of edible plants from Thailand. Cancer Lett95, 139—46.
33.
Murakami, A., Ohura, S., Nakamura, Y., Koshimizu, K., and Ohigashi, H. (1996). 1'-acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in ICR mouse skin. Oncology53, 386—91.
34.
Nakamura, Y., Murakami, A., Ohto, Y., Torikai, K., Tanaka, T., and Ohigashi, H. (1998). Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1'-acetoxychavicol acetate. Cancer Res58, 4832—9.
35.
Nicke, B., Kaiser, A., Wiedenmann, B., Riecken, E.O., and Rosewicz, S. (1999). Retinoic acid receptor alpha mediates growth inhibition by retinoids in human colon carcinoma HT29 cells. Biochem Biophys Res Commun261, 572—7.
36.
Noro, T., Sekiya, T., Katoh, M., Oda, Y., Miyase, T., Kuroyanagi, M., Ueno, A., and Fukushima, S. (1988). Inhibitors of xanthine oxidase from Alpinia galanga . Chem Pharm Bull36, 244—8.
37.
Ohata, T., Fukuda, K., Murakami, A., Ohigashi, H., Sugimura, T., and Wakabayashi, K. (1998). Inhibition by 1'-acetoxychavicol acetate of lipopolysaccharide- and interferon-gamma-induced nitric oxide production through suppression of inducible nitric oxide synthase gene expression in RAW264 cells. Carcinogenesis19, 1007—12.
38.
Ohnishi, M., Tanaka, T., Makita, H., Kawamori, T., Mori, H., Satoh, K., Hara, A., Murakami, A., Ohigashi, H., and Koshimizu, K. (1996). Chemopreventive effect of a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate, on rat oral carcinogenesis. Jpn J Cancer Res87, 349—56.
39.
Oikawa, T., Okayasu, I., Ashino, H., Morita, I., Murota, S., and Shudo, K. (1993). Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo. Euro J Pharm249, 113—16.
40.
Omori, M., Watanabe, M., Shidoji, Y., Moriwaki, H., and Muto, Y. (1996). Inhibitory effects of a timely dosing of acyclic retinoid on the development of spontaneous hepatomas in C3H/HeNCrj mice. Recent Adv Gastroenterol CarI, 523—26.
41.
Pence, B.C., and Reiners, J.J. Jr. (1987). Murine epidermal xanthine oxidase activity: correlation with degree of hyperplasia induced by tumor promoters. Cancer Res47, 6388—92.
42.
Tallman, M.S. and Wiernik, P.H. (1992). Retinoids in cancer treatment. J Clin Pharmacol32, 868—88.
43.
Tanaka, T., Kawabata, K., Kakumoto, M., Makita, H., Matsunaga, K., Mori, H., Satoh, K., Hara, A., Murakami, A., Koshimizu, K., and Ohigashi, H. (1997a). Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate . Jpn J Cancer Res88, 821—30.
44.
Tanaka, T., Makita, H., Kawamori, T., Kawabata, K., Mori, H., Murakami, A., Satoh, K., Hara, A., Ohigashi, H., and Koshimizu, K. (1997b). A xanthine oxidase inhibitor 1'-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats . Carcinogenesis18, 1113—8.
45.
Tanaka, T., and Mori, H. (1995). Inhibition of colon carcinogenesis by non-nutritive constituents in foods. J Toxic Pathol9, 139—49.
46.
Welsch, C.W. and DeHoog, J.V. (1983). Retinoid feeding, hormone inhibition, and/or immune stimulation and the genesis of carcinogen-induced rat mammary carcinomas. Cancer Res43, 585—91.
